U.S., Aug. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07142161) titled 'A Study on the Safety, Preliminary Efficacy, and Cellular Kinetics of Allo-CD7 CAR-T Cells in T1DM' on Aug. 19.
Brief Summary: This is an open clinical pharmacological translational Research Study, aiming to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of RD13-02 in patients with aT1DM
Study Start Date: July 20
Study Type: INTERVENTIONAL
Condition:
Type 1 Diabetes
Intervention:
DRUG: RD13-02 cell infusion
CAR T-cell therapy administered intravenously after a lymphodepleting therapy regimen consisting of fludarabine and cyclophosphami
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: Na...